Nifty
Sensex
:
:
21995.85
72488.99
-152.05 (-0.69%)
-454.69 (-0.62%)

Chemicals

Rating :
58/99

BSE: 543332 | NSE: EPIGRAL

1298.90
18-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1291.00
  •  1331.40
  •  1291.00
  •  1295.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  106981
  •  1395.24
  •  1400.00
  •  862.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5,392.59
  • 27.54
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 6,349.70
  • 0.39%
  • 4.57

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 71.38%
  • 2.28%
  • 21.19%
  • FII
  • DII
  • Others
  • 1.17%
  • 0.07%
  • 3.91%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.71
  • -
  • 38.23

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.47
  • -
  • 21.39

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 28.16
  • -
  • 51.88

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 18.82

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 5.27

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 10.78

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
471.52
537.84
-12.33%
478.15
555.53
-13.93%
454.89
532.85
-14.63%
562.18
498.79
12.71%
Expenses
348.75
371.31
-6.08%
370.24
375.24
-1.33%
359.70
345.39
4.14%
407.51
323.69
25.90%
EBITDA
122.77
166.53
-26.28%
107.91
180.29
-40.15%
95.19
187.46
-49.22%
154.66
175.10
-11.67%
EBIDTM
26.04%
30.96%
22.57%
32.45%
20.93%
35.18%
27.51%
35.11%
Other Income
2.46
-0.26
-
1.00
1.68
-40.48%
1.52
2.03
-25.12%
4.54
1.97
130.46%
Interest
20.19
21.03
-3.99%
21.27
14.36
48.12%
18.34
11.12
64.93%
18.99
11.82
60.66%
Depreciation
30.88
30.84
0.13%
31.51
25.95
21.43%
30.80
22.04
39.75%
30.13
21.06
43.07%
PBT
74.16
114.40
-35.17%
56.13
141.66
-60.38%
47.58
156.33
-69.56%
110.08
144.20
-23.66%
Tax
24.85
37.20
-33.20%
17.95
50.09
-64.16%
15.90
48.54
-67.24%
33.33
45.11
-26.11%
PAT
49.31
77.20
-36.13%
38.18
91.57
-58.31%
31.68
107.79
-70.61%
76.75
99.09
-22.55%
PATM
10.46%
14.35%
7.99%
16.48%
6.96%
20.23%
13.65%
19.87%
EPS
11.81
18.58
-36.44%
9.14
22.04
-58.53%
7.58
25.94
-70.78%
18.47
23.85
-22.56%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 21
Net Sales
1,966.74
2,188.40
1,550.94
828.60
Net Sales Growth
-7.45%
41.10%
87.18%
 
Cost Of Goods Sold
1,102.18
1,114.79
761.09
385.32
Gross Profit
864.56
1,073.62
789.85
443.28
GP Margin
43.96%
49.06%
50.93%
53.50%
Total Expenditure
1,486.20
1,499.45
1,041.45
567.27
Power & Fuel Cost
-
153.71
100.23
26.09
% Of Sales
-
7.02%
6.46%
3.15%
Employee Cost
-
68.85
51.99
41.26
% Of Sales
-
3.15%
3.35%
4.98%
Manufacturing Exp.
-
80.49
62.80
43.58
% Of Sales
-
3.68%
4.05%
5.26%
General & Admin Exp.
-
27.65
30.84
48.82
% Of Sales
-
1.26%
1.99%
5.89%
Selling & Distn. Exp.
-
29.36
17.02
4.50
% Of Sales
-
1.34%
1.10%
0.54%
Miscellaneous Exp.
-
24.60
17.49
17.70
% Of Sales
-
1.12%
1.13%
2.14%
EBITDA
480.53
688.95
509.49
261.33
EBITDA Margin
24.43%
31.48%
32.85%
31.54%
Other Income
9.52
9.29
8.34
7.47
Interest
78.79
66.81
48.50
34.40
Depreciation
123.32
108.95
85.91
73.54
PBT
287.95
522.48
383.42
160.86
Tax
92.03
169.17
130.64
60.02
Tax Rate
31.96%
32.38%
34.07%
37.31%
PAT
195.92
353.29
252.79
100.84
PAT before Minority Interest
195.92
353.29
252.79
100.84
Minority Interest
0.00
0.00
0.00
0.00
PAT Margin
9.96%
16.14%
16.30%
12.17%
PAT Growth
-47.85%
39.76%
150.68%
 
EPS
47.10
84.93
60.77
24.24

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Shareholder's Funds
1,069.10
725.97
684.13
Share Capital
41.55
41.55
252.47
Total Reserves
1,027.55
684.42
431.66
Non-Current Liabilities
715.44
865.41
375.96
Secured Loans
544.64
768.14
340.47
Unsecured Loans
0.00
0.00
0.00
Long Term Provisions
2.72
2.89
1.63
Current Liabilities
647.69
532.29
388.61
Trade Payables
110.17
88.11
73.05
Other Current Liabilities
445.56
354.44
240.33
Short Term Borrowings
91.71
80.14
75.03
Short Term Provisions
0.25
9.60
0.20
Total Liabilities
2,432.23
2,123.67
1,448.70
Net Block
1,804.05
1,067.83
1,102.31
Gross Block
2,319.70
1,474.54
1,423.69
Accumulated Depreciation
515.65
406.71
321.38
Non Current Assets
2,012.74
1,676.72
1,267.41
Capital Work in Progress
158.10
589.25
125.84
Non Current Investment
20.55
0.00
0.00
Long Term Loans & Adv.
29.60
17.85
35.02
Other Non Current Assets
0.44
1.79
4.24
Current Assets
419.50
446.94
181.29
Current Investments
0.00
0.00
0.00
Inventories
211.83
154.14
53.96
Sundry Debtors
166.32
256.32
118.84
Cash & Bank
15.11
25.09
0.68
Other Current Assets
26.24
3.87
3.16
Short Term Loans & Adv.
7.74
7.53
4.65
Net Current Assets
-228.19
-85.35
-207.32
Total Assets
2,432.24
2,123.66
1,448.70

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
626.16
283.82
229.22
PBT
522.48
383.42
160.86
Adjustment
170.35
130.25
102.62
Changes in Working Capital
40.82
-169.41
-5.65
Cash after chg. in Working capital
733.64
344.27
257.84
Interest Paid
0.00
0.00
0.00
Tax Paid
-107.48
-60.45
-28.62
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-437.22
-454.63
-196.73
Net Fixed Assets
-414.01
-514.26
Net Investments
-20.57
0.00
Others
-2.64
59.63
Cash from Financing Activity
-199.79
195.22
-31.90
Net Cash Inflow / Outflow
-10.85
24.41
0.58
Opening Cash & Equivalents
25.09
0.68
0.10
Closing Cash & Equivalent
14.24
25.09
0.68

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
257.30
174.72
113.88
ROA
15.51%
14.15%
6.96%
ROE
39.36%
42.16%
21.31%
ROCE
32.20%
29.40%
15.97%
Fixed Asset Turnover
1.22
1.11
0.61
Receivable days
33.28
42.65
50.07
Inventory Days
28.81
23.66
22.74
Payable days
32.46
38.64
69.20
Cash Conversion Cycle
29.63
27.66
3.61
Total Debt/Equity
0.82
1.36
0.79
Interest Cover
8.82
8.91
5.68

News Update:


  • Epigral - Quarterly Results
    24th Jan 2024, 12:48 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.